The identification of the miR-4262/PTEN/PI3 K/AKT axis as a novel regulator that controls PTX resistance in NSCLC provides new molecular insights for the development of new therapies for PTX resistance in NSCLC. Here, AKT1 is linked to non-small cell lung carcinoma.